Work

Abstract B037: COX-2 inhibitor enhances cabozantinib/Anti-PD1 efficacy in hepatocellular carcinoma

Year: 2026

Type: conference-abstract

Source: Cancer Immunology Research

DOI: 10.1158/2326-6074.io2026-b037

Authors: Yu-Chen Hsu, Meng-Chuan Wu, Meng-Tzu Weng, Ying-Te Lee, Ching-I Lin, Huei-Chi Chou, Hsuan-Shu Lee, Li-Fang Wang, Jin-Chuan Sheu, Chien-Hung Chen Chen

Institutions: National Taiwan University Hospital, National Taiwan University

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130555861

Cites:

Cited by:

Related to: